A Case of Cardiac Light Chain Deposition Disease in a Patient with Solitary Plasmacytoma
暂无分享,去创建一个
N. Gokden | M. Gokden | C. Schinke | M. Mohan
[1] D. Dingli,et al. Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis , 2013, Bone Marrow Transplantation.
[2] P. L. Bergsagel,et al. Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis. , 2012, Blood.
[3] D. Dingli,et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Dimopoulos,et al. Treatment of light chain deposition disease with bortezomib and dexamethasone , 2009, Haematologica.
[5] V. D’Agati,et al. A case of atypical light chain deposition disease--diagnosis and treatment. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[6] B. Barlogie,et al. Cardiac nonamyloidotic immunoglobulin deposition disease , 2006, Modern Pathology.
[7] M. Grassi,et al. Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient , 1998, The Italian Journal of Neurological Sciences.
[8] F. Locatelli,et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] T. Masuda,et al. Reversible restrictive cardiomyopathy due to light-chain deposition disease. , 2002, Mayo Clinic proceedings.
[10] I. Kronzon,et al. Infiltrative Nonamyloidotic Monoclonal Immunoglobulin Light Chain Cardiomyopathy: An Underappreciated Manifestation of Plasma Cell Dyscrasias , 2000, Cardiology.
[11] Ramée,et al. Congestive heart failure: revealing light chain deposition disease. , 2000, European journal of internal medicine.
[12] E. Hatzimichael,et al. A Patient with Multiple Myeloma, Amyloidosis and Light-Chain Deposition Disease in Kidneys with a Long Survival , 1999, Acta Haematologica.
[13] C. Girelli,et al. Kappa light chain deposition disease of the liver. , 1998, European journal of gastroenterology & hepatology.
[14] A. Moreau,et al. Lambda light chain deposition disease presenting as sicca syndrome. , 1997, Arthritis and rheumatism.
[15] A. Berrebi,et al. Case report: multiple myeloma presenting as a diastolic heart failure with no evidence of amyloidosis. , 1995, The American journal of the medical sciences.
[16] M. Mihatsch,et al. Ocular Pathology in Light Chain Deposition Disease , 1995, European journal of ophthalmology.
[17] S. Walton,et al. Systemic lambda light-chain deposition presenting with predominant cardiac involvement. , 1993, Postgraduate medical journal.
[18] J. Velosa,et al. Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.